PainChek Ltd (ASX: PCK) - Share Price
Current share price for PCK : $0.115 0.005 (4.55%)+
PainChek Ltd (PCK), an ASX-listed company, is the world's first regulatory-cleared medical device for the assessment of pain, enabling best-practice pain management for people living with pain in any environment, from those who cannot reliably self-report their pain, those who can, and for those whose ability to self-report their pain fluctuates.
PCK General Information +
| ASX Code | PCK |
| Website | http://painchek.com |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 24 |
| PCK Share Price | $0.115 |
| Day High | $0.115 |
| Day Low | $0.110 |
| Last Close | $0.110 |
| PCK Share Price Movement | $0.01 ( 4.55% ) |
Prices as at 16:40, 10 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
PainChek Ltd (PCK) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from PainChek Ltd (PCK) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
PainChek Ltd (PCK) price-sensitive announcements
PCK - CEO Transition
PainChek Ltd announced the immediate transition of its CEO and Managing Director, Philip D
PainChek Ltd (PCK)
6 Jul 2026 | 4:33 PM
6 Jul 2026 | 4:33 PM
PCK - PainChek secures A$5.5m note to fund US expansion
PainChek Ltd has announced a A$5.5 million convertible note financing to support its expan
PainChek Ltd (PCK)
22 May 2026 | 9:05 AM
22 May 2026 | 9:05 AM
PCK - Quarterly Activities/Appendix 4C Cash Flow Report
PainChek Ltd (ASX: PCK) reported significant growth in its March 31, 2026 quarterly activi
PainChek Ltd (PCK)
30 Apr 2026 | 11:18 AM
30 Apr 2026 | 11:18 AM
PCK - Landmark Sabra North America deployment targeting 20k beds
PainChek Ltd has entered into a significant Master Services Agreement with Sabra Health Ca
PainChek Ltd (PCK)
14 Apr 2026 | 9:19 AM
14 Apr 2026 | 9:19 AM
PainChek Ltd (PCK) Recent ASX Announcements
PCK Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$7.67 | -$4.40 | -20.90% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$8.31 | -$5.60 | -3.00% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$7.57 | -$5.80 | 15.70% | 0.00 | 0.00 | 0.00% | 0.0% |
PCK Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| 4DMedical Limited (4DX) | $2,427M | 0.3304 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| PainChek Ltd (PCK) | $23M | -0.2093 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $21,983M | 0.3919 | 0.2545 | 0.2962 | 191.1172 | 152.3458 | 117.5334 | 0.26% | 0.33% | 0.44% |
PCK Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | -19.20 | 0.00 |
| Market | 0.28 | 13.10 | 1.15 | 0.59 |
| Sector | 0.67 | 23.50 | 1.63 | 2.04 |
PCK Directors
| Name | Position | Start Date |
|---|---|---|
| Ms Lilian (Lil) Bianchi | Non-Executive Chairman, Non-Executive Director | 25 May 2026 |
| Mr Adam Stuart Davey | Non-Executive Director | 29 Sep 2014 |
| Mr John Murray | Non-Executive Director | 30 Sep 2016 |
| Mr Ross Harricks | Non-Executive Director | 30 Sep 2016 |
| Ms Cynthia Payne | Non-Executive Director | 30 Mar 2022 |
PainChek Ltd (PCK) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 22 Dec 2025 | DAFFAS, Philip | Issued | Direct Shares | 147,059 | $0.340 | $50,000.000 |
| 22 Dec 2025 | PAYNE, Cynthia | Issued | Direct Shares | 29,412 | $0.340 | $10,000.000 |
| 19 Dec 2024 | DAVEY, Adam | Issued | Indirect Shares | 767,280 | $0.025 | $19,182.000 |
See all changes in directors' interest & trades for PainChek Ltd (PCK) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
PCK Management
| Name | Position |
|---|---|
| Andy Hoggan | Chief Operating Officer,Interim Chief Executive Officer |
| Natalie Sylvia Climo | Company Secretary |
PCK Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in PainChek Ltd (PCK). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 133,481,250 (6.47%) | Peters Investments Pty Ltd |
PCK Calendar of Events
| Date | Event |
|---|---|
| 26 February 2027 | Report (Interim) |
| 29 September 2026 | Report (Annual) |
| 28 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
